{"title":"OSR1和SIX2在人肾细胞中驱动不同的转录程序:对再生和肿瘤发生的影响。","authors":"Naomi Pode-Shakked, Osnat Cohen-Zontag, Dorit Omer, Orit Harari-Steinberg, Einav Vax, Oren Pleniceanu, Benjamin Dekel","doi":"10.3389/fbioe.2025.1645499","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The nephron progenitor cells generate approximately one million nephrons during human nephrogenesis. At 34-36 weeks of human genstation, silencing of the key kidney progenitor genes results in depletion of this progenitor pool, limiting the regeneration capacity of the mature kidney. Concurrently, the increasing incidence of end-stage kidney disease underscores the urgent need for innovative regenerative strategies.</p><p><strong>Methods: </strong>We employed lentiviral vectors to ectopically induce two key kidney progenitor genes <i>OSR1</i> and <i>SIX2</i> individually or together in primary human adult kidney (hAK) cells. We then analyzed the cellular and molecular consequences through morphological assessments, functional assays, <i>in vivo</i> transplantation studies, and comprehensive transcriptional profiling.</p><p><strong>Results: </strong><i>OSR1</i> and <i>SIX2</i> induced distinct reprogramming processes with differential functional outcomes; <i>SIX2</i> overexpression was found to maintain epithelial morphology while significantly enhancing proliferation and clonogenic efficiency. Transcriptionally, <i>SIX2</i> established epithelialization and cell-cycle networks by downregulating proximal tubule markers while upregulating distal nephron markers and proliferation genes. <i>In vivo</i>, <i>SIX2</i>-expressing cells formed organized tubular structures with a distinct luminal architecture in a proof-of-concept model. In contrast, <i>OSR1</i> overexpression was found to induce morphological changes and activate developmental morphogenetic pathways, including epithelial tube morphogenesis and canonical <i>Wnt</i> signaling; however, it did not enhance proliferation and showed minimal tubulogenic capacity <i>in vivo</i>. Unexpectedly, <i>OSR1</i> overexpression led to malignant transformation in one clone and exhibited Wilms'-tumor-like features, including expression of kidney developmental markers (i.e., SIX2, NCAM1, and WT1) and blastemal phenotype.</p><p><strong>Conclusion: </strong>Our findings suggest that <i>SIX2</i> overexpression in primary hAK cells functionally confers enhanced self-renewal and tubulogenic capacity while transcriptionally inducing a proximal-to-distal tubular cell diversion with maintained proliferative programs. In contrast, <i>OSR1</i> activates the broader developmental morphogenetic networks but poses potential oncogenic risks. The malignant transformation observed with <i>OSR1</i> overexpression provides insights into the potential cellular origins of Wilms' tumor and raises important safety considerations for regenerative medicine approaches involving developmental gene induction in adult kidney cells.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1645499"},"PeriodicalIF":4.8000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531215/pdf/","citationCount":"0","resultStr":"{\"title\":\"<i>OSR1</i> and <i>SIX2</i> drive divergent transcriptional programs in human kidney cells: implications for regeneration and tumorigenesis.\",\"authors\":\"Naomi Pode-Shakked, Osnat Cohen-Zontag, Dorit Omer, Orit Harari-Steinberg, Einav Vax, Oren Pleniceanu, Benjamin Dekel\",\"doi\":\"10.3389/fbioe.2025.1645499\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The nephron progenitor cells generate approximately one million nephrons during human nephrogenesis. At 34-36 weeks of human genstation, silencing of the key kidney progenitor genes results in depletion of this progenitor pool, limiting the regeneration capacity of the mature kidney. Concurrently, the increasing incidence of end-stage kidney disease underscores the urgent need for innovative regenerative strategies.</p><p><strong>Methods: </strong>We employed lentiviral vectors to ectopically induce two key kidney progenitor genes <i>OSR1</i> and <i>SIX2</i> individually or together in primary human adult kidney (hAK) cells. We then analyzed the cellular and molecular consequences through morphological assessments, functional assays, <i>in vivo</i> transplantation studies, and comprehensive transcriptional profiling.</p><p><strong>Results: </strong><i>OSR1</i> and <i>SIX2</i> induced distinct reprogramming processes with differential functional outcomes; <i>SIX2</i> overexpression was found to maintain epithelial morphology while significantly enhancing proliferation and clonogenic efficiency. Transcriptionally, <i>SIX2</i> established epithelialization and cell-cycle networks by downregulating proximal tubule markers while upregulating distal nephron markers and proliferation genes. <i>In vivo</i>, <i>SIX2</i>-expressing cells formed organized tubular structures with a distinct luminal architecture in a proof-of-concept model. In contrast, <i>OSR1</i> overexpression was found to induce morphological changes and activate developmental morphogenetic pathways, including epithelial tube morphogenesis and canonical <i>Wnt</i> signaling; however, it did not enhance proliferation and showed minimal tubulogenic capacity <i>in vivo</i>. Unexpectedly, <i>OSR1</i> overexpression led to malignant transformation in one clone and exhibited Wilms'-tumor-like features, including expression of kidney developmental markers (i.e., SIX2, NCAM1, and WT1) and blastemal phenotype.</p><p><strong>Conclusion: </strong>Our findings suggest that <i>SIX2</i> overexpression in primary hAK cells functionally confers enhanced self-renewal and tubulogenic capacity while transcriptionally inducing a proximal-to-distal tubular cell diversion with maintained proliferative programs. In contrast, <i>OSR1</i> activates the broader developmental morphogenetic networks but poses potential oncogenic risks. The malignant transformation observed with <i>OSR1</i> overexpression provides insights into the potential cellular origins of Wilms' tumor and raises important safety considerations for regenerative medicine approaches involving developmental gene induction in adult kidney cells.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1645499\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531215/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1645499\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1645499","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
OSR1 and SIX2 drive divergent transcriptional programs in human kidney cells: implications for regeneration and tumorigenesis.
Background: The nephron progenitor cells generate approximately one million nephrons during human nephrogenesis. At 34-36 weeks of human genstation, silencing of the key kidney progenitor genes results in depletion of this progenitor pool, limiting the regeneration capacity of the mature kidney. Concurrently, the increasing incidence of end-stage kidney disease underscores the urgent need for innovative regenerative strategies.
Methods: We employed lentiviral vectors to ectopically induce two key kidney progenitor genes OSR1 and SIX2 individually or together in primary human adult kidney (hAK) cells. We then analyzed the cellular and molecular consequences through morphological assessments, functional assays, in vivo transplantation studies, and comprehensive transcriptional profiling.
Results: OSR1 and SIX2 induced distinct reprogramming processes with differential functional outcomes; SIX2 overexpression was found to maintain epithelial morphology while significantly enhancing proliferation and clonogenic efficiency. Transcriptionally, SIX2 established epithelialization and cell-cycle networks by downregulating proximal tubule markers while upregulating distal nephron markers and proliferation genes. In vivo, SIX2-expressing cells formed organized tubular structures with a distinct luminal architecture in a proof-of-concept model. In contrast, OSR1 overexpression was found to induce morphological changes and activate developmental morphogenetic pathways, including epithelial tube morphogenesis and canonical Wnt signaling; however, it did not enhance proliferation and showed minimal tubulogenic capacity in vivo. Unexpectedly, OSR1 overexpression led to malignant transformation in one clone and exhibited Wilms'-tumor-like features, including expression of kidney developmental markers (i.e., SIX2, NCAM1, and WT1) and blastemal phenotype.
Conclusion: Our findings suggest that SIX2 overexpression in primary hAK cells functionally confers enhanced self-renewal and tubulogenic capacity while transcriptionally inducing a proximal-to-distal tubular cell diversion with maintained proliferative programs. In contrast, OSR1 activates the broader developmental morphogenetic networks but poses potential oncogenic risks. The malignant transformation observed with OSR1 overexpression provides insights into the potential cellular origins of Wilms' tumor and raises important safety considerations for regenerative medicine approaches involving developmental gene induction in adult kidney cells.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.